The members of the Board of Directors and Executive Committee reflected in the table below held 0.2% of the outstanding shares as at 31 December 2022 and 0.2% as at 31 December 2021. Other than as indicated in the table below, no persons or entities closely associated with members of the Board of Directors or Executive Committee held any shares as of 31 December 2022 or 31 December 2021, respectively. Table 16 does not include any unvested PSUs.
Name |
Role |
Shares held as at 31 December 2022 |
Shares held as at 31 December 2021 |
|
|||
Board of Directors 1 |
|||
Peter Wilden |
Chairman |
8,402 |
1,658 |
Patrick Aebischer |
Vice-Chairman, Lead Independent Director |
5,318 |
1,105 |
Erik Schropp 2 |
Member |
3,193 |
3,193 |
Jane Salik |
Member |
19,553 |
17,737 |
Beat In-Albon |
Independent Member |
4,787 |
995 |
Philippe Weber |
Independent Member |
5,835 |
1,225 |
|
|||
Executive Committee |
|||
Raymond De Vré 3 |
CEO |
16,486 |
16,486 |
Jan Fuhr Miller |
CFO |
7,767 |
7,767 |
Jan Christensen 4 |
Director Global Sales and Marketing |
n/a |
7,767 |
Daniel Lasanow 5 |
Director Global Operations |
7,767 |
7,767 |
Christina Del Vecchio |
General Counsel |
– |
– |
Neil James Thompson 6 |
Director Global Sales and Marketing |
1,122 |
1,122 |
Jens Fricke 7 |
Director Global Operations |
1,380 |
1,380 |
As of 31 December 2022, Raymond De Vré held a total of 6,606 PSUs with respect to grants made under the LTIP in 2021. As announced on 30 January 2023, Mr. De Vré resigned as CEO, and his contractual six-month notice period will end on 31 July 2023.
There were no LTIP awards made in 2022.
As of 31 December 2022, none of the members of the Board of Directors or the Executive Committee, or any persons closely associated with any member, held any stock options.